CRISPR Therapeutics AG (CRSP)
49.25
-2.27
(-4.41%)
USD |
NASDAQ |
Oct 16, 16:00
49.18
-0.07
(-0.14%)
After-Hours: 20:00
CRISPR Therapeutics Net Income (TTM) : -451.14M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -451.14M |
| March 31, 2026 | -568.53M |
| December 31, 2025 | -581.60M |
| September 30, 2025 | -488.30M |
| June 30, 2025 | -467.80M |
| March 31, 2025 | -385.66M |
| December 31, 2024 | -366.25M |
| September 30, 2024 | -239.59M |
| June 30, 2024 | -265.80M |
| March 31, 2024 | -217.14M |
| December 31, 2023 | -153.61M |
| September 30, 2023 | -353.53M |
| June 30, 2023 | -415.93M |
| March 31, 2023 | -524.02M |
| December 31, 2022 | -650.18M |
| September 30, 2022 | -680.85M |
| June 30, 2022 | -633.45M |
| March 31, 2022 | 311.61M |
| December 31, 2021 | 377.66M |
| September 30, 2021 | 411.87M |
| June 30, 2021 | 446.58M |
| Date | Value |
|---|---|
| March 31, 2021 | -392.30M |
| December 31, 2020 | -348.86M |
| September 30, 2020 | -211.28M |
| June 30, 2020 | 19.58M |
| March 31, 2020 | 45.54M |
| December 31, 2019 | 66.86M |
| September 30, 2019 | -11.27M |
| June 30, 2019 | -200.41M |
| March 31, 2019 | -185.09M |
| December 31, 2018 | -164.98M |
| September 30, 2018 | -117.25M |
| June 30, 2018 | -91.25M |
| March 31, 2018 | -75.18M |
| December 31, 2017 | -68.36M |
| September 30, 2017 | -51.40M |
| June 30, 2017 | -41.39M |
| March 31, 2017 | -36.24M |
| December 31, 2016 | -23.20M |
| September 30, 2016 | -43.97M |
| June 30, 2016 | -32.79M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Vertex Pharmaceuticals, Inc. | 4.405B |
| Basilea Pharmaceutica AG | 66.07M |
| Santhera Pharmaceuticals Holding AG | -40.37M |
| BeOne Medicines Ltd. | 657.23M |
| Intellia Therapeutics, Inc. | -399.98M |